Home / Inspections / 1020396

FDA Inspection 1020396 — Minaris Regenerative Medicine, LLC

Minaris Regenerative Medicine, LLC — FEI 3003407523

The FDA completed an inspection of Minaris Regenerative Medicine, LLC on April 26, 2017 in Allendale, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Allendale, NJ (United States)

Facility

Other inspections at this facility

  • 1284408 (VAI Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1101234 (NAI Mon Aug 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886646 (NAI Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources